| Amedisys Hospice Of Lawrenceville 595 Hurricane Shoals Road, Nw Suite 201, Lawrenceville, GA, 30046 | |
| (678) 442-7338 |
News Archive
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Where you live and how you view your neighbourhood is strongly related to your health behaviour and your risk of developing obesity, according to research published this week.
The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.
The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.
Illinois state Rep. John Fritchey (D) on Tuesday introduced a bill (HB 5840) that would repeal and replace a parental notification law revived recently by the state Supreme Court, the AP/Belleville News Democrat reports.
› Verified 1 days ago
| Name | Amedisys Hospice Of Lawrenceville |
|---|---|
| Location | 595 Hurricane Shoals Road, Nw Suite 201, Lawrenceville, Georgia |
| Hospice ID | 111665 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| SSA county code | 530 |
News Archive
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Where you live and how you view your neighbourhood is strongly related to your health behaviour and your risk of developing obesity, according to research published this week.
The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.
The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.
Illinois state Rep. John Fritchey (D) on Tuesday introduced a bill (HB 5840) that would repeal and replace a parental notification law revived recently by the state Supreme Court, the AP/Belleville News Democrat reports.
› Verified 1 days ago
| NPI Number | 1427173699 |
| Organization Name | Adventa Hospice, Llc |
| Address | 595 Hurricane Shoals Rd Nw Lawrenceville, Georgia, 30046 |
| Phone Number | (678)442-7338 |
News Archive
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Where you live and how you view your neighbourhood is strongly related to your health behaviour and your risk of developing obesity, according to research published this week.
The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.
The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.
Illinois state Rep. John Fritchey (D) on Tuesday introduced a bill (HB 5840) that would repeal and replace a parental notification law revived recently by the state Supreme Court, the AP/Belleville News Democrat reports.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 93.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.8 | 97.3 |
| Patients who got timely treatment for shortness of breath | 90.4 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 92.9 | 93.3 |
News Archive
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Where you live and how you view your neighbourhood is strongly related to your health behaviour and your risk of developing obesity, according to research published this week.
The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.
The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.
Illinois state Rep. John Fritchey (D) on Tuesday introduced a bill (HB 5840) that would repeal and replace a parental notification law revived recently by the state Supreme Court, the AP/Belleville News Democrat reports.
› Verified 1 days ago
| Home Health Aides | 7 |
| Counselors | 1.25 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 2 |
| Physicians | 0.5 |
| Registered Nurses | 11 |
| Other Personnel | 5.25 |
| Total Employees | 28 |
|---|
News Archive
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Where you live and how you view your neighbourhood is strongly related to your health behaviour and your risk of developing obesity, according to research published this week.
The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.
The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.
Illinois state Rep. John Fritchey (D) on Tuesday introduced a bill (HB 5840) that would repeal and replace a parental notification law revived recently by the state Supreme Court, the AP/Belleville News Democrat reports.
› Verified 1 days ago
| Others | 9 |
| Total Volunteers | 9 |
|---|
News Archive
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a "tumor-tropic liposome technology" for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery than viruses used as carriers.
Where you live and how you view your neighbourhood is strongly related to your health behaviour and your risk of developing obesity, according to research published this week.
The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.
The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.
Illinois state Rep. John Fritchey (D) on Tuesday introduced a bill (HB 5840) that would repeal and replace a parental notification law revived recently by the state Supreme Court, the AP/Belleville News Democrat reports.
› Verified 1 days ago
| Mesun Location: 88 Johnson Road, Lawrenceville, Georgia, 30046 Phone: (678) 442-7338 |
| Amedisys Hospice Of Lawrenceville Location: 595 Hurricane Shoals Road, Nw Suite 201, Lawrenceville, Georgia, 30046 Phone: (678) 442-7338 |
| Embrace Hospice Location: 1585 Old Norcross Road Suite 205, Lawrenceville, Georgia, 30046 Phone: (678) 442-7338 |
| Agape Hospice Of Northeast Georgia Location: 575 Old Norcross Road, Suite A, Lawrenceville, Georgia, 30045 Phone: (678) 442-7338 |